Anti-NGF antibodies and methods using same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9212222
SERIAL NO

13302264

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention concerns anti-NGF antibodies (such as anti-NGF antagonist antibodies), and polynucleotides encoding the same. The invention further concerns use of such antibodies and/or polynucleotides in the treatment and/or prevention of pain, including post-surgical pain, rheumatoid arthritis pain, and osteoarthritis pain.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RINAT NEUROSCIENCE CORP66 HUDSON BOULEVARD EAST LEGAL PATENT DEPT CHIEF IP COUNSEL NEW YORK NY 10001-2192

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Pons, Jaume San Francisco, US 98 2170
Rosenthal, Arnon Woodside, US 193 2102

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 15, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00